Month: February 2026

Nasdaq CopenhagenEuronext DublinLondon Stock ExchangeOther stakeholders 4 February 2025Ringkjøbing Landbobank’s annual report for 2025 The bank’s board of directors and general management today approved the annual report for 2025. For 2025, net profit at the top of the announced expectations for the year is realized with DKK 2,313 million. The bank is satisfied with this development.Core earnings(DKK million) 2025 2024 2023 2022 2021Total core income 4,089 4,068 3,828 2,862 2,433Total expenses and depreciation 1,080 1,044 963 891 817Core earnings before impairment charges for loans 3,009 3,024 2,865 1,971 1,616Impairment charges for loans etc. +41 +3 -1 -2 -68Core earnings 3,050 3,027 2,864 1,969 1,548Result for the portfolio etc. +26 +62 -7 -69 +7Special costs 20 20 20 20 17Profit before tax 3,056 3,069 2,837 1,880 1,538Profit...

Equinor (OSE: EQNR, NYSE: EQNR) will on 5 February 2026 commence the first tranche of up to USD 375 million of the share buy-back programme for 2026, as announced in relation with the company’s fourth quarter results on 4 February 2026. In this first tranche of the share buy-back programme for 2026, shares for up to USD 123.75 million will be purchased in the market, implying a total tranche of up to USD 375 million including shares to be redeemed from the Norwegian State. The tranche will end no later than 30 March 2026. Equinor announces a share buy-back programme of up to USD 1.5 billion for 2026, including shares to be redeemed from the Norwegian State. The share buy-back programme will be subject to market outlook and balance sheet strength and be structured into tranches where Equinor will buy back shares for a certain value in USD...

Key information relating to the proposed cash dividend to be paid by Equinor (OSE: EQNR, NYSE: EQNR) for fourth quarter 2025. Cash dividend amount: 0.39 Announced currency: USD Last day including rights: 12 May 2026 Ex-date Oslo Børs: 13 May 2026 Ex-date New York Stock Exchange: 15 May 2026 Record date: 15 May 2026 Payment date: 27 May 2026 Date of approval: the proposed cash dividend is subject to approval by the annual general meeting of Equinor ASA on 12 May 2026. Other information: The cash dividend per share in NOK will be communicated 21 May 2026. This information is published in accordance with the requirements of the Continuing Obligations and is subject to the disclosure requirements pursuant to Section 5-12 in the Norwegian Securities Trading Act.

Melbourne, Australia, Feb. 03, 2026 (GLOBE NEWSWIRE) — Nova Minerals Limited (“Nova” or the “Company”) (NASDAQ: NVA) (ASX: NVA) (FRA: QM3) ) a gold and critical minerals exploration stage company focused on advancing the Estelle Gold and Critical Minerals Project in Alaska, U.S.A., announces that, following the loss of its foreign private issuer (FPI) status effective 1 July 2026, it intends to undertake a corporate reorganization. This will include a planned redomiciliation to the United States while maintaining its dual ASX and Nasdaq listings, pursuing the acquisition of the remaining 15% interest in the Estelle Gold and Critical Minerals Project, and initiating a search for a U.S.-based Chief Financial Officer (CFO) with significant mining sector and U.S. GAAP accounting experience. Highlights •    As a result of the majority...

Human lung tissue analyses identify iNKT cell depletion as a mechanistic feature of advanced IPF Findings extend MiNK’s iNKT platform into chronic fibrotic lung disease and support immune restoration strategies in IPF, a large unmet-need marketLEXINGTON, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) — MiNK Therapeutics (Nasdaq: INKT) today announced that new translational data supporting the role of invariant natural killer T (iNKT) cells in idiopathic pulmonary fibrosis (IPF) were presented at the Emerging Cell Therapies Meeting of the Keystone Symposia on Molecular and Cellular Biology, taking place February 1–4, 2026, in Banff, Alberta, Canada. The data, presented by Dr. Terese Hammond, Head of Pulmonary and Inflammatory Diseases at MiNK Therapeutics and a Pulmonary and Critical Care physician, demonstrate a significant depletion...

Perth, Western Australia, Feb. 04, 2026 (GLOBE NEWSWIRE) — HALF YEAR FY26 RESULTS – INVESTOR WEBINAR / CALL Perseus Mining Limited (ASX/TSX: PRU) is hosting an investor webinar and conference call to discuss its H1 FY26 Results, which are anticipated for release around 8:30am AEDT on Friday 20 February 2026. CALL DETAILSAustralia: Friday 20 February 2026 Perth – 7:00am Sydney/Melbourne – 10:00am Canada: Thursday 19 February 2026 Vancouver – 3:00pm Toronto – 6:00pm UK: Thursday 19 February 2026 London – 11:00pmRegister for the investor webinar at the link below: https://us02web.zoom.us/webinar/register/WN_zUglK1fgQxmnopXVAfS9VA After registering, you will receive a confirmation email containing information about joining the webinar. To join the webinar via telephone, please use one of the following numbers and enter...

TIANJIN, China, Feb. 04, 2026 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (Nasdaq: NTWK), a provider of AI-enabled solutions and services enabling OEMs, dealerships and financial institutions to sell, finance and lease assets, announced that NETSOL China’s wholly-owned subsidiary, Tianjin Nuojin Zhicheng Technology Co., Ltd., has successfully passed China’s National High-Tech Enterprise certification and has subsequently been awarded the ‘National High-Tech Enterprise Certificate’.  This certification is an authoritative, state-level evaluation of a company’s core independent R&D capabilities and technological innovation system. It signifies that NETSOL has established a local technology entity in China that meets national technical and regulatory requirements, providing a solid foundation for long-term, sustainable R&D...